Disruption of estrogen-regulated gene expression by dioxin: Downregulation of a gene associated with the onset of non-insulin-dependent diabetes mellitus (type 2 diabetes)

Human and Experimental Toxicology

Volumn 23, Issue 12, 2004, Pages 555-564

  Hokanson, Regina ^a   Miller, Susan ^a   Hennessey, Maxine ^c   Flesher, Mark ^b   Hanneman, William ^c   Busbee, David ^a,b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c Veterinary Dentistry and Oral Surgery   (United States)

Author keywords

DNA microarray analysis; Endocrine disruptive chemicals; Estrogen antagonist; Real time PCR; TCDD; Type 2 diabetes

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; DIOXIN; DNA; ENDOCRINE DISRUPTOR; ESTRADIOL; FULVESTRANT; INSULIN RECEPTOR SUBSTRATE 1;

ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; EVALUATION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENETIC DISORDER; HORMONAL REGULATION; HUMAN; HUMAN CELL; MITOSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE;

ANIMALS; CELL LINE; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ESTRADIOL; ESTRADIOL ANTAGONISTS; GENE EXPRESSION REGULATION; MITOSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHOPROTEINS; TETRACHLORODIBENZODIOXIN; TIME FACTORS;

MINK CELL FOCUS-FORMING VIRUS;

EID: 11844273930     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1191/0960327104ht488oa     Document Type: Article

References (65)

1. Fuller P. The steroid receptor superfamily: mechanisms of diversity. FASEB J 1991; 5: 3092-97.
2. Truss M, Beato M. Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocrinol Rev 1993; 14: 450-79.
3. Lieberman BA. The estrogen receptor activity cycle: dependence on multiple protein-protein interaction. Crit Rec In Endocr Gene Expr 1997; 7: 43-59.
4. Safe S. 2,3,7,8-Tetrachlorodibenzo-p-dioxin, and related halogenated aromatic hydrocarbons: examination of mechanisms of toxicity. Toxicol 1990; 21: 51-88.
5. Jackson TF, Halbert FL. A toxic syndrome associated with the feeding of polybrominated biphenyl-contaminated protein concentrate to dairy cattle. J Am Vet Med Assn 1974; 165: 437-39.
6. Constable JD, Hatch MC. Reproductive effects of herbicide exposure in Vietnam: recent studies by the Vietnamese and others. Terat Carcinogen Mutagen 1985; 5: 231-50.
7. Kashimoto T, Miyata H. Differences between Yusho and other kinds of poisoning involving only PCBs. In Waid JS ed. PCBs and the environment. Boca Raton, FL: CRC Press, 1994.
8. Lawrence C, Reilly A, Quyickenton P, Greenwald P, Page W, Kuntz A. Mortality patterns of New York State Vietnam veterans. Am J Public Health 1985; 75: 277-83.
9. Colborn T, Vom Saal FS, Soto AM. Developmental effects of endocrine-disruptive chemicals in wildlife and humans. Environ Health Perspect 1993; 101: 378-83.
10. Abbott BD, Perdew GH, Buckalew AR, Birnbaum LS. Interactive regulation of Ah and glucocorticoid receptors in the synergistic induction of cleft palate by TCDD and hydrocortisone. Toxicol Appl Pharmacol 1994; 128: 138-50.
11. Theobald HM, Roman BL, Lin T-M, Ohtani S, Chen S-W, Peterson RE. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits luminal cell differentiation and androgen responsiveness of the ventral prostate without inhibiting prostatic 5-dihydrotesterone formation or testicular androgen production in rat offspring. Toxicol Sci 2000; 58: 324-38.
12. Parks LG, Ostby JS, Lambright CR, Abbott BD, Klinefelter GR, Barlow NJ, Gray LE Jr. The plasticizer diethylphthalate induces malformations by decreasing fetal testosterone synthesis during sexual differentiation in the male rat. Toxicol Sci 2000; 58: 339-49.
13. Laws SC, Ferrell JM, Stoker TE, Schmid J, Cooper RL. The effects of atrazine of female Wistar rats: an evaluation of the protocol for assessing pubertal development and thyroid function. Toxicol Sci 2000; 58: 366-76.
14. Colborn T, Clement C. Chemically-induced alterations in sexual and functional development: the wildlife/ human connection. Princeton, NJ: Princeton Scientific Publishing, 1992.
15. Colon I, Caro D, Bourdony CJ, Rosario O. Identification of phthalate esters in the serum of young Puerto Rican girls with premature breast development. Environ Health Perspect 2000; 108: 895-900.
16. Chen PH, Hsu ST. PCB poisoning from toxic rice-bran oil in Taiwan. In Waid JS ed. PCBs and the environment, Vol. 3. Boca Raton, FL: CRC Press, 1987.
17. Hoffman RE. Recent studies of the human immunotoxic effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin. In Newcombe DS, Rose NR, Bloom JC eds. Clinical immunotoxicology. New York: Raven Press, 1992; 339-48.
18. De Swart RI, Kluten RMG, Huizing CJ, Vedder EJ, Reijnders PJH et al. Mitogen and antigen induced B and T cell responses of peripheral blood mononuclear cells from the harbour seal (Phoca vitulina). Vet Immunol & Immunopath 1993; 37: 217-30.
19. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. Persistent DDT metabolite p,p′-DDE is a potent androgen receptor antagonist. Nature 1995; 375: 581-85.
20. Brouwer A, Ahlborg UG, Vandenberg M, Birnbaum LS, Boersma ER, Bosveld B et al. Functional aspects of developmental toxicity of polyhalogenated aromatic hydrocarbons in experimental animals and human infants. Eur J Pharm Environ Toxicol Pharm 1995; 293: 1-40.
21. Guillette LJ, Pickford DB, Crain DA, Rooney AA, Percival HF. Reduction in penis size and plasma testosterone concentrations in juvenile alligators living in a contaminated environment. Gen Comp Endocrinol 1996; 101: 32-42.
22. Santostefano MJ, Wang X, Richardson VM, Ross DG, DeVito MJ, Birnbaum LS. A pharmacodynamic analysis of TCDD-induced cytochrome P450 gene expression in multiple tissues: dose-and time-dependent effects. Toxicol Applied Pharmacol 1998; 151: 294-310.
23. Roman BL, Peterson RE. In utero and lactational exposure of the male rat to 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs prostate development: effects on gene expression. Toxicol Appl Pharmacol 1998; 150: 240-53.
24. Roman BL, Timms BG, Prins GS, Peterson RE. In utero and lactational exposure of the male rat to 2,3,7,8-tetrachlorodibenzo-p-dioxin impairs prostate development: effects on growth and cytodifferentiation. Toxicol Appl Pharmacol 1998; 150: 254-70.
25. Vickers PJ, Dufresne MJ, Cowan KH. Relation between cytochrome P4501A1 expression and estrogen receptor content of human breast cancer cells. Mol Endo 1989; 3: 157-64.
26. Zacharewski TR, Bondy KL, McDonell P, Wu ZF. Antiestrogenic effect of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 β-estradiol-induced pS2 expression. Can Res 1994; 54: 2707-13.
27. Rier SE, Martin DC, Bowman RE, Becker JL. Immunoresponsiveness in endometriosis: implications of estrogenic toxicants. Env Health Perspec 1995; 103 (Suppl 7): 151-56.
28. Faqi AS, Dalsenter PR, Merker H-J, Chahoud I. Reproductive toxicity and tissue concentrations of low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin in male offspring rats exposed throughout pregnancy and lactation. Toxicol Appl Pharmacol 1998; 150: 383-92.
29. Tanabe S, Tatsukawa R, Maruyama K, Miyazaki N. Transplancental transfer of PCBs and chlorinated hydrocarbon pesticides from the pregnant striped dolphin (Stenella coeruleoalba) to her fetus. Agric Biol Chem 1982; 46: 1249-54.
30. Ridgway S, Reddy M. Residue levels of several organochlorines in Tursiops truncatus milk collected at varied stages of lactation. Mar Poll Bull 1995; 30: 609-14.
31. Blount BC, Silva MJ, Caudill SP, Needham LL, Pirkle JL, Sampson EJ et al. Levels of seven urinary phthalate metabolites in a human reference population. Environmental Health Perspectives 2000; 108: 972-82.
32. Davidson LA, Lupton JR, Miskovsky E, Fields AP and Chapkin RS. Quantification of human intestinal gene expression profiles using exfoliated colonocytes: a pilot study. Biomarkers 2003; 8: 51-61.
33. Miller S, Kennedy D, Thomson J, Han F, Smith R, Ing N, Piedrahita J, Busbee D. A rapid and sensitive reporter gene system using green fluorescent protein expression to detect chemicals with estrogenic activity. Toxicol Sci 2000; 55: 69-77.
34. Soto AM, Justicia H, Wray JW, Sonnenschein C. p-Nonylphenol: an estrogenic xenobiotic released from 'modified' polystyrene. Environ Health Persp 1991; 92: 167-73.
35. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994; 135: 175-82.
36. Miller S, Han F, Prado J, Busbee D. Estradiol receptors in dolphin kidney endothelial cells: detection and comparison with estrogen receptors from MCF7 cells. In Vitro & Molecular Toxicology 2000; 13: 199-211.
37. Gray LE Jr, Ostby J, Furr J, Price M, Veeramachaneni DNR, Parks L. Perinatal exposure to the phthalates DEHP, BBP, and DINP, but not DEP, DMP, or DOTP, alters sexual differentiation of the male rat. Toxicol Sci 2000; 58: 350-65.
38. Wang L-M, Myers MG Jr, Sun X-J, Aaronson MW, Pierce JH. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 1993; 261: 1591-95.
39. Kramer V, Helferich W, Bergman A, Klasson-Wehler E, Giesy JP. Hydroxylated polychlorinated biphenyl metabolites are anti-estrogenic in a stably transfected human breast adenocarcinoma (MCF-7) cell line. Tox Appl Pharmacol 1997; 144: 363-76.
40. Kharat I, Saatcioglu F. Antiestrogenic effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin are mediated by direct transcriptional interference with the liganded estrogen receptor. J Biol Chem 1996; 271: 10533-37.
41. Lu Y, Wang X, Safe S. Interaction of 2,3,7,8-tetrachlorodibenzo-p-dioxin and retinoic acid in MCF-7 human breast cancer cells. Tox Appl Pharm 1994; 127: 1-8.
42. Zacharewski T. In vitro bioassays for assessing estrogenic substances. Env Sci Tech 1997; 31: 613-23.
43. Wang X, Porter W, Krishnan V, Narasimhan TR, Safe S. Mechanism of 2,3,7,8-tetrachloro-p-dioxin (TCDD)-mediated decrease of the nuclear estrogen receptor in MCF-7 human breast cancer cells. Mol Cell Endo 1993; 96: 159-66.
44. Safe S, Wang F, Porter W, Duan R, McDougal A. Ah receptor agonists as endocrine disruptors: antiestrogenic activity and mechanisms. Toxicol Lett 1998; 102-103: 343-47.
45. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991; 352: 73-77.
46. Stoffel M, Espinosa R III, Keller SR, Lienhard GE, Le Beau M, Bell GI. Human insulin receptor substrate-1 gene (IRS1): chromosomal localization to 2q35-q36.1 and identification of a simple tandem repeat DNA polymorphism. Diabetologia 1993; 36: 335-37.
47. Nishiyama M, Inazawa J, Ariyama T, Nakamura Y, Matsufuji S, Furusaka A et al. The human insulin receptor substrate-1 gene (IRS1) is localized on 2q36. Genomics 1994; 20: 139-41.
48. O'Malley B, Tsai M-J. Molecular pathways of steroid receptor action. Biol Repro 1992; 46: 163-67.
49. Moller DE, Bjorbaek C, Vidal-Puig A. Candidate genes for insulin resistance. Diabetes Care 1996; 19: 396-400.
50. Institute of Medicine. Veterans and Agent Orange: Herbicide/Dioxin Exposure and Type 2 Diabetes. Institute of Medicine, National Academy Press, 2000.
51. Almind K, Inoue G, Pedersen O, Kahn CR. A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling: evidence from transfection studies. J Clin Invest 1996; 97: 2569-75.
52. Rother KI, Imai Y, Caruso M, Beguinot F, Formissano P, Accili D. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 1998; 273: 17491-97.
53. Maor G, Karnieli E. The insulin-sensitive glucose transporter (GLUT4) is involved in early bone growth in control and diabetic mice, but is regulated through the insulin-like growth factor 1 receptor. Endocrinology 1999; 140: 1841-51.
54. Patki V, Tuft R, Corvera S. Sites of insulin action on GLUT4 trafficking revealed by ultra-fast digital imaging microscopy. Diabetes 2000; 50: 593-609.
55. Egawa K, Nakashima N, Sharma PM, Maegawa H, Olefsky JM. Expression of membrane targeted PO-3 kinase enhances insulin-induced IRS-1 degradation in 3T3-L1 adipocytes. Diabetes 2000; 48: 328-33.
56. Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H et al. Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 1988; 240: 787-90.
57. Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T et al. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature 1994; 372: 182-86.
58. Kido Y, Kanno H, Withers DJ, Burks DJ, Accili D. Interaction between insulin receptor and IRS proteins in IR/IRS-[1.sup.+/-] and IR/IRS-[2.sup.+/-] mice. Diabetes 2000; 48: 10-22.
59. Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 1992; 340: 925-29.
60. Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwold S, Pedersen O. Amino acid polymorphisms of insulin receptor substrate-1 in non-insulin- dependent diabetes mellitus. Lancet 1993; 342: 828-33.
61. Lei H, Coresh J, Shuldiner A, Boerwinkle E, Brancati F. Variants of the insulin receptor substrate-1 and fatty acid binding protein 2 genes and the risk of type 2 diabetes, obesity, and hyperinsulinemia in African-Americans: The Atherosclerosis Risk in Communities Study. Diabetes 1999; 48: 1862-68.
62. Weisnagel J, Chagnon YC, Rankinen T, Nadeau A, Chagnon M, Perusse L, Bouchard C. The insulin receptor substrate-1 (IRS-1) Gly972Arg polymorphism is associated with obesity in the Quebec family study (GFS). Diabetes 2000; 49: 199-201.
63. Clausen JO, Hansen T, Bjorbaek C, Echwald, SM, Urhammer SA, Rasmussen S et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 1995; 346: 397-402.
64. Baroni MG, Oelbaum RS, Pozzilli P, Stocks J, Li S-R, Fiore V, Galton DJ. Polymorphisms at the GLUT1 (HepG2) and GLUT4 (muscle/adiposite) glucsose transporter genes and non-insulin-dependent diabetes mellitus (NIDDM). Hum Genet 1992; 88: 557-61.
65. Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D et al. The gly-to-arg(972) amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. J Clin Endocr Metab 2000; 85: 2004-2013.